BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18635970)

  • 41. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture.
    Kawada N; Ikeda K; Seki S; Kuroki T
    J Hepatol; 1999 Jun; 30(6):1057-64. PubMed ID: 10406184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
    Baker GL; Landis MW; Hinds PW
    Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
    Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
    Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.
    Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ
    Am J Pathol; 2000 Sep; 157(3):1039-50. PubMed ID: 10980142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
    Ewen ME; Sluss HK; Sherr CJ; Matsushime H; Kato J; Livingston DM
    Cell; 1993 May; 73(3):487-97. PubMed ID: 8343202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells.
    Chaves-Ferreira M; Krenn G; Vasseur F; Barinov A; Gonçalves P; Azogui O; Cumano A; Li Z; Pellegrini S; Rocha B; Laderach D
    Biol Direct; 2016 Apr; 11():21. PubMed ID: 27129404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1.
    Lahti JM; Li H; Kidd VJ
    J Biol Chem; 1997 Apr; 272(16):10859-69. PubMed ID: 9099742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells.
    Mori N; Fujii M; Hinz M; Nakayama K; Yamada Y; Ikeda S; Yamasaki Y; Kashanchi F; Tanaka Y; Tomonaga M; Yamamoto N
    Int J Cancer; 2002 May; 99(3):378-85. PubMed ID: 11992406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
    Ajchenbaum F; Ando K; DeCaprio JA; Griffin JD
    J Biol Chem; 1993 Feb; 268(6):4113-9. PubMed ID: 8382693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.
    Knudsen KE; Cavenee WK; Arden KC
    Cancer Res; 1999 May; 59(10):2297-301. PubMed ID: 10344732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.
    Wang X; Sistrunk C; Miliani de Marval PL; Kim Y; Rodriguez-Puebla ML
    Cell Cycle; 2012 Jan; 11(2):335-42. PubMed ID: 22214766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1.
    Lee HW; Nam KO; Park SJ; Kwon BS
    Eur J Immunol; 2003 Aug; 33(8):2133-41. PubMed ID: 12884287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
    Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y
    Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
    Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
    Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death?
    Timsit S; Rivera S; Ouaghi P; Guischard F; Tremblay E; Ben-Ari Y; Khrestchatisky M
    Eur J Neurosci; 1999 Jan; 11(1):263-78. PubMed ID: 9987030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies to mammalian D-type G1 cyclins.
    Vallance SJ; Lee HM; Roussel MF; Shurtleff SA; Kato JY; Strom DK; Sherr CJ
    Hybridoma; 1994 Feb; 13(1):37-44. PubMed ID: 8200657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase.
    Bacon CL; Gallagher HC; Haughey JC; Regan CM
    J Neurochem; 2002 Oct; 83(1):12-9. PubMed ID: 12358724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.
    Hanse EA; Mashek DG; Becker JR; Solmonson AD; Mullany LK; Mashek MT; Towle HC; Chau AT; Albrecht JH
    Cell Cycle; 2012 Jul; 11(14):2681-90. PubMed ID: 22751438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice.
    Mataraza JM; Tumang JR; Gumina MR; Gurdak SM; Rothstein TL; Chiles TC
    J Immunol; 2006 Jul; 177(2):787-95. PubMed ID: 16818732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.